ARTICLE | Company News
Vanderbilt University, La Jolla Pharmaceutical deal
October 5, 2015 7:00 AM UTC
La Jolla and the university partnered to develop small molecule kinase inhibitors discovered at the university, which selectively block members of the bone morphogenetic protein receptor type I (BMPRI) family. La Jolla will fund the research and have the right to purchase exclusive, worldwide rights to compounds arising from the research. ...